Analysis of metallothionein and vimentin immunoreactivity in pharyngeal squamous cell carcinoma and its microenvironment

Cell and Tissue Research

Volumn 352, Issue 2, 2013, Pages 341-349

  Dutsch Wicherek, Magdalena ^a   Lazar, Agata ^b   Tomaszewska, Romana ^b   Kazmierczak, Wojciech ^c,d   Wicherek, Lukasz ^d  

^a Regional Oncology Centre Bydgoszcz   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c A Jurasz 1st University Hospital   (Poland)

^d NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Cancer microenvironment; Cancer associated fibroblasts; Human; Metallothionein (MT); Vimentin

Indexed keywords

CD56 ANTIGEN; CD57 ANTIGEN; METALLOTHIONEIN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORPHOLOGY; CANCER PROGNOSIS; CHRONIC TONSILLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPHOCYTE COUNT; MALE; MOLECULAR PATHOLOGY; PALATINE TONSIL; PHARYNX CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; TUMOR MICROENVIRONMENT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FIBROBLASTS; HEAD AND NECK NEOPLASMS; HUMANS; MALE; METALLOTHIONEIN; MIDDLE AGED; PHARYNGEAL NEOPLASMS; VIMENTIN;

EID: 84880570640     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-013-1566-1     Document Type: Article

References (36)

1. Acevedo VD, Gangula RD, Freeman KW, Li R, Zhang Y, Wang F, Ayala GE, Peterson LE, Ittmann M, Spencer DM (2007) Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell 12:559-571
2. Apostolova MD, Cherian MG (2000) Nuclear localization of metallothionein during cell proliferation and differentiation. Cell Mol Biol 46:347-356
3. Araujo VC de, Pinto Júnior DS, Sousa SO de, Nunes FD, Araujo NS de (1993) Vimentin in oral squamous cell carcinoma. Eur Arch Otorhinolaryngol 250:105-109
4. Borghesi LA, Youn J, Olson EA, Lynes MA (1996) Interactions of metallothionein with murine lymphocytes: plasma membrane binding and proliferation. Toxicology 108:129-140
5. Canpolat E, Lynes MA (2001) In vivo manipulation of endogenous metallothionein with a monoclonal antibody enhances a T-dependent humoral immune response. Toxicol Sci 62:61-70
6. Cherian MG, Jayasurya A, Bay BH (2003) Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 33:201-209
7. De Wever O, Mareel M (2005) Role of tissue stroma in cancer cell invasion. J Pathol 200:429-447
8. Dutsch-Wicherek M, Popiela TJ, Klimek M, Rudnicka-Sosin L, Wicherek L, Oudinet JP, Skladzien J, Tomaszewska R (2005) Metallothioneinstroma reaction in tumor adjacent healthy tissue in head and neck squamous cell carcinoma and breast adenocarcinoma. Neuro Endocrinol Lett 26:567-574
9. Dutsch-Wicherek M, Sikora J, Tomaszewska R (2008) The possible biological role of metallothionein in apoptosis. Front Biosci 13:4029-4038
10. Dutsch-Wicherek M, Lazar A, Tomaszewska R (2010) The potential role of MT and vimentin immunoreactivity in the remodeling of the microenvironment of parotid adenocarcinoma. Cancer Microenviron 4:105-113
11. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650-1659
12. Grunert S, Jechlinger M, Beug H (2003) Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 4:657-665
13. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D, Cunha GR (2001) Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 61:8135-8142
14. Hellquist HB (1997) Apoptosis in epithelial hyperplastic laryngeal lesions. Acta Otolaryngol Suppl 527:25-29
15. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213:374-383
16. Jayasurya A, Bay BH, Yap WM, Tan NG (2000) Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma. Br J Cancer 82:1198-1203
17. Jozwicki W, Windorbska W, Brozyna AA, Jochymski C, Basta P, Sikora J, Stasienko E, Dutsch-Wicherek M, Koper K, Wicherek L (2011) The analysis of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) immunoreactivity within the microenvironment of the ovarian cancer lesion relative to the applied therapeutic strategy. Cell Tissue Res 345:405-414
18. Klaassen CD, Liu J, Choudhuri S (1999) Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol 39:267-294
19. Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL (2004) Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 10:3755-3762
20. Lorusso G, Ruegg C (2008) The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 130:1091-1103
21. Okada T, Iiai T, Kawachi Y, Moroda T, Takii Y, Hatakeyama K, Abo T (1995) Origin of CD57+ T cells which increase at tumor sites in patients with colorectal cancer. Clin Exp Immunol 102:159-166
22. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-348
23. Paccione RJ, Miyazaki H, Patel V, Waseem A, Gutkind JS, Zehner ZE, Yeudall WA (2008) Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility. Mol Cancer Ther 7:2894-2903
24. Popiela TJ, Rudnicka-Sosin L, Dutsch-Wicherek M, Klimek M, Basta P, Galazka K, Wicherek L (2006) The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity. Neuro Endocrinol Lett 27:786-794
25. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB (1999) Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 277:C1-C9
26. Sallusto F, Geminat J, Lanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745-763
27. Satelli A, Li S (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68:3033-3046
28. Satoh M, Seki S, Hashimoto W, Ogasawara K, Kobayashi T, Kumagai K, Matsuno S, Takeda K (1996) Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. J Immunol 157:3886-3892
29. Shimoda R, Achanzar WE, Qu W, Nagamine T, Takagi H, Mori M, Waalkes MP (2003) Metallothionein is a potential negative regulator of apoptosis. Toxicol Sci 73:294-300
30. Sundelin K, Jadner M, Norberg-Spaak L, Davidsson A, Hellquist HB (1997) Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue. Eur J Cancer 33:1860-1864
31. Takii Y, Hashimoto S, Iiai T, Watanabe H, Hatakeyama K, Abo T (1994) Increase of the proportion of granulated CD56+ T cells in patients with malignancy. J Clin Exp Immunol 97:522-527
32. Theocharis SE, Margeli AP, Klijanienko JT, Kouraklis GP (2004) 617 Metallothionein expression in human neoplasia. Histopathology 618:103-118
33. Vered M, Allon I, Buchner A, Dayan D (2009) Stromal myofibroblasts accompany modifications in the epithelial phenotype of tongue dysplastic and malignant lesions. Cancer Microenviron 2:49-57
34. Witz IP (2009) The tumor microenvironment: the making of a paradigm. Cancer Microenviron 2:S9-S17
35. Xu J, Wang R, Xie ZH, Odero-Marah V, Pathak S, Multani A, Chung LW, Zhau HE (2006) Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 66:1664-1673
36. Yin X, Knecht DA, Lynes MA (2005) Metallothionein mediates leukocyte chemotaxis. BMC Immunol 6:21